SCOPUS 정보 검색 플랫폼

Breast Cancer Research and Treatment

Volumn 75, Issue SUPPL. 1, 2002, Pages

New generation aromatase inhibitors - From the advanced to the adjuvant setting

(1) Buzdar, Aman U a

a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER (United States)

Author keywords

Advanced breast cancer; Anastrozole; Aromatase inhibitors; Estrogen receptor; Postmenopausal

Indexed keywords

ANASTROZOLE; AROMATASE INHIBITOR; CYTOCHROME P450; ESTROGEN RECEPTOR; EXEMESTANE; GLUCOCORTICOID; LETROZOLE; MEGESTROL ACETATE; TAMOXIFEN;

ADVANCED CANCER; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER SURVIVAL; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; HEADACHE; HUMAN; NAUSEA; POSTMENOPAUSE; PRIORITY JOURNAL; REVIEW; STEROID METABOLISM; VOMITING; WEIGHT GAIN;

EID: 0036776751 PISSN: 01676806 EISSN: None Source Type: Journal
DOI: 10.1023/a:1020305615033 Document Type: Review

Times cited : (21)

References (15)

1
- 0035464108
- Aromatase, aromatase inhibitors, and breast cancer
- (2001) Am J Ther , vol.8 , pp. 333-344
- Brueggemeier, R.W.¹

2
- 0020078292
- Aminoglutethimide as treatment of postmenopausal women with advanced breast carcinoma
- (1982) Ann Intern Med , vol.96 , pp. 94-101
- Santen, R.J.¹ Worgul, T.J.² Lipton, A.³ Harvey, H.⁴ Boucher, A.⁵ Samojlik, E.⁶ Wells, S.A.⁷

3
- 0033744956
- An overview of the use of non-steroidal aromatase inhibitors in the treatment of breast cancer
- (2000) Eur J Cancer , vol.36 , Issue.SUPPL. 4
- Buzdar, A.¹

4
- 0032530988
- Anastrozole versus megestrol acetate in the treatment of postmenopausal women with advanced breast carcinoma: Results of a survival update based on a combined analysis of data from two mature phase III trials
- Arimidex Study Group
- (1998) Cancer , vol.83 , pp. 1142-1152
- Buzdar, A.U.¹ Jonat, W.² Howell, A.³ Jones, S.E.⁴ Blomqvist, C.P.⁵ Vogel, C.L.⁶ Eiermann, W.⁷ Wolter, J.M.⁸ Steinberg, M.⁹ Webster, A.¹⁰ Lee, D.¹¹

5
- 0031943424
- Letrozole, a new oral aromatase inhibitor for advanced breast cancer: Double-blind randomized trial showing a dose effect and improved efficacy and tolerability compared with megestrol acetate
- (1998) J Clin Oncol , vol.16 , pp. 453-461
- Dombernowsky, P.¹ Smith, I.² Falkson, G.³ Leonard, R.⁴ Panasci, L.⁵ Bellmunt, J.⁶ Bezwoda, W.⁷ Gardin, G.⁸ Gudgeon, A.⁹ Morgan, M.¹⁰ Fornasiero, A.¹¹ Hoffmann, W.¹² Michel, J.¹³ Hatschek, T.¹⁴ Tjabbes, T.¹⁵ Chaudri, H.A.¹⁶ Hornberger, U.¹⁷ Trunet, P.F.¹⁸

6
- 0035879215
- Phase III multicenter, double-blind, randomized study of letrozole, an aromatase inhibitor, for advanced breast cancer versus megestrol acetate
- (2001) J Clin Oncol , vol.19 , pp. 3357-3366
- Buzdar, A.¹ Douma, J.² Davidson, N.³ Elledge, R.⁴ Morgan, M.⁵ Smith, R.⁶ Porter, L.⁷ Nabholtz, J.⁸ Xiang, X.⁹ Brady, C.¹⁰

7
- 0034128928
- Exemestane is superior to megestrol acetate after tamoxifen failure in postmenopausal women with advanced breast cancer: Results of a phase III randomized double-blind trial
- The Exemestane Study Group
- (2000) J Clin Oncol , vol.18 , pp. 1399-1411
- Kaufmann, M.¹ Bajetta, E.² Dirix, L.Y.³ Fein, L.E.⁴ Jones, S.E.⁵ Zilembo, N.⁶ Dugardyn, J.L.⁷ Nasurdi, C.⁸ Mennel, R.G.⁹ Cervek, J.¹⁰ Fowst, C.¹¹ Polli, A.¹² Di Salle, E.¹³ Arkhipov, A.¹⁴ Piscitelli, G.¹⁵ Miller, L.L.¹⁶ Massimini, G.¹⁷

8
- 0034669484
- Anastrozole is superior to tamoxifen as first-line therapy for advanced breast cancer in postmenopausal women: Results of a North American multicenter randomized trial
- Arimidex Study Group
- (2000) J Clin Oncol , vol.18 , pp. 3758-3767
- Nabholtz, J.M.¹ Buzdar, A.² Pollak, M.³ Harwin, W.⁴ Burton, G.⁵ Mangalik, A.⁶ Steinberg, M.⁷ Webster, A.⁸ Von Euler, M.⁹

9
- 0034669435
- Anastrozole versus tamoxifen as first-line therapy for advanced breast cancer in 668 postmenopausal women: Results of the Tamoxifen or Arimidex Randomized Group Efficacy and Tolerability Study
- (2000) J Clin Oncol , vol.18 , pp. 3748-3757
- Bonneterre, J.¹ Thürlimann, B.² Robertson, J.F.³ Krzakowski, M.⁴ Mauriac, L.⁵ Koralewski, P.⁶ Vergote, I.⁷ Webster, A.⁸ Steinberg, M.⁹ Von Euler, M.¹⁰

10
- 0035498544
- Anastrozole is superior to tamoxifen as first-line therapy in hormone receptor positive advanced breast carcinoma
- (2001) Cancer , vol.92 , pp. 2247-2258
- Bonneterre, J.¹ Buzdar, A.² Nabholtz, J.M.³ Robertson, J.F.⁴ Thurlimann, B.⁵ Von Euler, M.⁶ Sahmoud, T.⁷ Webster, A.⁸ Steinberg, M.⁹

11
- 0343584508
- Superior efficacy of letrozole versus tamoxifen as first-line therapy for postmenopausal women with advanced breast cancer: Results of a phase III study of the International Letrozole Breast Cancer Group
- (2001) J Clin Oncol , vol.19 , pp. 2596-2606
- Mouridsen, H.¹ Gershanovich, M.² Sun, Y.³ Perez-Carrion, R.⁴ Boni, C.⁵ Monnier, A.⁶ Apffelstaedt, J.⁷ Smith, R.⁸ Sleeboom, H.P.⁹ Janicke, F.¹⁰ Pluzanska, A.¹¹ Dank, M.¹² Becquart, D.¹³ Bapsy, P.P.¹⁴ Salminen, E.¹⁵ Snyder, R.¹⁶ Lassus, M.¹⁷ Verbeek, J.A.¹⁸ Staffler, B.¹⁹ Chaudri-Ross, H.A.²⁰ Dugan, M.²¹ more..

12
- 0003200605
- Efficacy of and tolerance to exemestane (E) versus tamoxifen (T) in 1st line hormone therapy (HT) of postmenopausal metastatic breast cancer (MBC) patients (pts): A European Organisation for the Research and Treatment of Cancer (EORTC Breast Group) phase II trial with Pharmacia and Upjohn
- San Francisco, CA, May 12-15, abstract 114
- (2001) ASCO 2001
- Dirix, L.¹ Piccart, M.J.² Lohrisch, C.³ Beex, L.⁴ Nooij, M.⁵ Cameron, D.⁶ Biganzoli, L.⁷ Cufer, T.⁸ Yague, C.⁹ Duchateau, L.¹⁰ Lobelle, J.P.¹¹ Paridaens, R.¹²

13
- 0028170545
- Arimidex: A potent and selective fourth-generation aromatase inhibitor
- (1994) Breast Cancer Res Treat , vol.30 , pp. 103-111
- Plourde, P.V.¹ Dyroff, M.² Dukes, M.³

14
- 0033082373
- Double-blind, randomised, multicentre endocrine trial comparing two letrozole doses, in postmenopausal breast cancer patients
- (1999) Eur J Cancer , vol.35 , pp. 208-213
- Bajetta, E.¹ Zilembo, N.² Dowsett, M.³ Guillevin, L.⁴ Di Leo, A.⁵ Celio, L.⁶ Martinetti, A.⁷ Marchiano, A.⁸ Pozzi, P.⁹ Stani, S.¹⁰ Bichisao, E.¹¹

15
- 0035717875
- Comparative clinical pharmacology and pharmacokinetic interactions of aromatase inhibitors
- (2001) J Steroid Biochem Mol Biol , vol.79 , pp. 85-91
- Boeddinghaus, I.M.¹ Dowsett, M.²

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.